Director Of Financial Modeling
CurrentLeading a Medical Pharmacy underwriting and pricing team of 10 FTE’s supporting programs for drugs used for Oncology, Oncology Support, Biological Diseases and Auto Immune Diseases, Immune Globulin, Hepatitis C, and Multiple Sclerosis therapies for Health Plans and Large Employer groups.Managing the construction and presentation of market analytics and company specific savings opportunities for existing and potential clients. Performed Ad-hoc analytics supporting Quarterly Business reviews, sales, and drug trend reporting.Modeled the impact of changes in reimbursements based on Prior Authorization, Post-Service Claim Edits, Least Cost Alternatives, Shifting of the site of care, and IVIG dose optimization for Medical Pharmacy Drugs.